The abstract is read at the publisher; the summary is JClub's.
Adaptive optics enables in vivo, single-cell–level imaging of multiple human retinal cell types, including photoreceptors, RPE, immune cells, and microvasculature, across FIAO, AO-OCT, and AOSLO platforms.
- Why it matters: Traditional retinal imaging largely characterizes tissue and layer pathology, while direct observation of individual living cells has been constrained by ocular aberrations, optical contrast, and image-analysis limits.
- What they did: The review surveys three AO-enhanced approaches—FIAO, AO-OCT, and AOSLO—highlighting complementary en face, depth-resolved volumetric, and confocal/non-confocal or fluorescence-based contrast, plus advances like faster correction, wider-field acquisition, compressed multichannel imaging, sensorless AO, and AI-assisted reconstruction, segmentation, and quantification.
- The result: Molecular labeling is extending imaging toward cellular and molecular biomarkers, including ICG for RPE mosaic contrast, annexin V–based DARC for retinal stress/apoptosis readouts, and curcumin-based amyloid marker exploration in Alzheimer’s disease.
The findingWhy it mattersWhat they didThe result
AI summary of the abstract · may contain errors · not medical advice · read the paper.